On this page
Meacham syndrome
This syndrome primarily impacts foetal development, leading to conditions such as ambiguous genitalia and kidney issues. It is a very rare disorder, caused by pathogenic variants in the WT1 gene, and is inherited in an autosomal dominant manner.
Available at Jeen Health
Clinical tests that include this
Overview
Meacham syndrome is a very rare genetic disorder that affects the development of several body systems, most notably the kidneys and the genital and urinary tracts. Individuals with Meacham syndrome often present with a combination of these developmental differences, which can vary in their specific presentation and severity. The condition is present from birth, as it arises from disruptions during foetal development.
Because of its rarity, understanding of Meacham syndrome continues to evolve through ongoing research. The clinical features can range, but commonly include differences in sex development (DSD) and issues with kidney function, which require specialised medical care.
Symptoms & clinical features
The primary clinical features of Meacham syndrome involve the kidneys and the development of the genital and urinary systems. Individuals with the condition often have ambiguous genitalia, meaning their external sex organs do not clearly appear to be either male or female [PMID:11979401]. This can be due to a range of underlying developmental anomalies affecting the gonads (testes or ovaries) and other reproductive structures.
Kidney involvement is also a significant aspect of Meacham syndrome. This can manifest as structural abnormalities of the kidneys, which may affect their function. While the specific kidney problems can vary, they often require careful monitoring and management to ensure optimal renal health [PMID:17967919].
Video: Genetics 101
Affected organs
Meacham syndrome predominantly affects the kidneys and the organs involved in sexual and urinary development. The kidneys may show structural differences, which can lead to impaired function. The reproductive organs and external genitalia are also significantly impacted, often resulting in ambiguous genitalia or other forms of differences in sex development.
Beyond these primary systems, some individuals may have other associated features, though these are less consistently observed. The core impact of Meacham syndrome is on the genitourinary system, highlighting the crucial role of the underlying genetic cause in early development.
Risks & severity
The severity of Meacham syndrome can vary significantly among affected individuals, even within the same family. Kidney problems can range from mild to severe, potentially leading to chronic kidney disease requiring long-term medical management. The degree of ambiguous genitalia also varies, impacting decisions around gender assignment and subsequent medical interventions.
While Meacham syndrome is primarily a developmental condition, pathogenic variants in the WT1 gene, which cause the syndrome, are also associated with an increased risk of certain types of cancer, particularly Wilms tumour [PMID:17967919]. Wilms tumour is a type of kidney cancer that typically affects children. Regular surveillance for this risk is an important part of managing the condition.
Genetic causes
Meacham syndrome is caused by pathogenic changes in the WT1 gene. The WT1 gene provides instructions for making a protein called Wilms tumour 1, which acts as a transcription factor. This means it controls the activity of many other genes. The WT1 protein is critically important for the normal development of several organs during the foetal period, particularly the kidneys and the reproductive organs [PMID:11979401].
When there is a pathogenic variant in the WT1 gene, the protein may not function correctly, or its production may be altered. This disruption in gene regulation during foetal development leads to the characteristic features of Meacham syndrome, affecting the structure and function of the kidneys and the development of the genital and urinary systems.
- WT1 WT1 transcription factorThe WT1 gene provides instructions for a protein essential for the development of the kidneys and gonads, playing a critical role in cell growth, differentiation, and programmed cell death.
Inheritance pattern
Meacham syndrome is inherited in an autosomal dominant pattern. This means that a person only needs one copy of the altered WT1 gene in each cell to develop the condition. In some cases, an affected individual inherits the pathogenic variant from one of their parents who also has the condition.
However, it is also common for Meacham syndrome to occur as a 'de novo' (new) pathogenic variant, meaning the genetic change happens for the first time in the affected individual and is not inherited from either parent. In such cases, the parents typically do not have the condition and do not carry the pathogenic variant. Each child of an individual with Meacham syndrome has a 50% chance of inheriting the pathogenic variant.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis of Meacham syndrome typically begins with the recognition of its characteristic clinical features, such as ambiguous genitalia and evidence of kidney developmental issues. A definitive diagnosis is established through genetic testing to identify a pathogenic variant in the WT1 gene. Such testing is usually performed by a clinical genetics service.
Referrals for genetic testing in the UK can be made via the NHS Genomic Medicine Service (GMS). This typically involves an R-code (e.g., R146 Congenital anomalies of the kidney and urinary tract (CAKUT); R148 Differences of sex development) that allows for targeted gene panel testing or whole genome sequencing. A clinical geneticist or specialist paediatrician would generally coordinate this diagnostic pathway, often in consultation with a genetic counsellor.
Management & lifestyle
Management for individuals with Meacham syndrome involves a multidisciplinary team approach, often including paediatricians, endocrinologists, urologists, nephrologists, and genetic counsellors. The specific care plan is tailored to the individual's presenting symptoms and needs.
For ambiguous genitalia, decisions regarding gender assignment and potential surgical interventions are made in consultation with families and medical specialists, taking into account long-term health and psychosocial outcomes. Kidney function is closely monitored, and any renal issues are managed symptomatically. Given the increased risk of Wilms tumour, regular screening, such as abdominal ultrasound scans, is typically recommended to detect any tumour development early [PMID:17967919]. Genetic counselling is crucial to help families understand the inheritance pattern and implications for future family planning.
UK care pathway
In the UK, individuals suspected of having Meacham syndrome would typically be referred to a clinical genetics service as part of the NHS Genomic Medicine Service pathway. This service facilitates genetic testing, often using specific R-codes for conditions involving kidney anomalies or differences in sex development. Following diagnosis, ongoing care is provided by specialist teams, including paediatricians and relevant organ-specific specialists.
Genetic counsellors are an integral part of this pathway, offering support and information to families regarding the genetic implications, inheritance patterns, and the availability of resources. This integrated approach aims to provide comprehensive care and support for affected individuals and their families.
Frequently asked questions
What is ambiguous genitalia?
Ambiguous genitalia refers to external sex organs that do not clearly appear male or female. This can make it difficult to assign a gender at birth and often requires further medical investigation and specialist care.
Is Meacham syndrome always inherited from a parent?
No, Meacham syndrome is not always inherited. While it can be passed down from an affected parent, it commonly arises from a new (de novo) genetic change in the affected individual, meaning neither parent carries the pathogenic variant.
What is the risk of cancer with Meacham syndrome?
Individuals with Meacham syndrome have an increased risk of developing Wilms tumour, a type of kidney cancer that typically affects children. Regular screening, such as ultrasound scans, is usually recommended to detect this early.
Where can I get support for Meacham syndrome in the UK?
In the UK, support for Meacham syndrome is typically accessed through the NHS. Clinical genetics services, specialist paediatric teams, and genetic counsellors can provide information, medical care, and guidance on support networks.
Can Meacham syndrome affect future pregnancies?
If an individual with Meacham syndrome plans to have children, there is a 50% chance for each child to inherit the condition due to its autosomal dominant inheritance pattern. Genetic counselling can provide detailed information and options for family planning.
References
- Adam MP, Bick S, Mirzaa GM. WT1 Disorder. 1993. PMID: 32352694
- Lopez-Gonzalez M, Ariceta G. WT1-related disorders: more than Denys-Drash syndrome. Pediatric nephrology (Berlin, Germany). 2024. PMID: 38326647
- Suri M, Kelehan P, O'neill D. WT1 mutations in Meacham syndrome suggest a coelomic mesothelial origin of the cardiac and diaphragmatic malformations. American journal of medical genetics. Part A. 2007. PMID: 17853480
- Moszczyńska E, Miszczuk O, Baszyńska-Wilk M. Meacham syndrome in a patient with gonadal dysgenesis, congenital cardiac malformations, and short stature. Endokrynologia Polska. 2026. PMID: 42053338
- Alves D, Leão M. The clinical overlap between cardiac-urogenital syndrome, Meacham syndrome, and PAGOD syndrome. Report of a new patient with cardiac-urogenital syndrome. American journal of medical genetics. Part A. 2020. PMID: 32181572
- Killeen OG, Kelehan P, Reardon W. Double vagina with sex reversal, congenital diaphragmatic hernia, pulmonary and cardiac malformations--another case of Meacham syndrome. Clinical dysmorphology. 2002. PMID: 11822701
- Cho HY, Lee BS, Kang CH. Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect. Pediatric nephrology (Berlin, Germany). 2006. PMID: 16932893
- Costin M, Cinteză EE, Croitoru A. WT1-Related Nephropathy in a Phenotypically Female Child: A Case of Clinical and Genetic Discordance. Children (Basel, Switzerland). 2025. PMID: 40426774